23/09/2026 08:00
Caledonia Mining Corporation Plc: Notification of Relevant Change to Significant Shareholder
pstrong id=datelineSAINT HELIER, JE / a href=https://www.accessnewswire.com/ACCESS Newswire/a / September 23, 2026 / /strongCaledonia Mining Corporation Plc "Caledonia" or "the Company" announces that it received notification on September 22, 2026 from BlackRock, Inc. that on... Lire...
23/09/2026 07:30
EQS-News: Mutares has sold Prénatal Netherlands to its CEO Jochem van Bueren
html xmlns=http://www.w3.org/1999/xhtmlbody table border=trtd p EQSNews: Mutares SE & Co. KGaA / Key words: Disposal/Investment br/ Mutares has sold Prénatal Netherlands to its CEO Jochem van Bueren br/br/ 23.09.2026 / 07:30... Lire...
23/09/2026 07:30
EQS-News: Baader Bank and RoboMarkets announce partnership
html xmlns=http://www.w3.org/1999/xhtmlbody table border=trtd p EQSNews: Baader Bank AG / Key words: Alliance br/ Baader Bank and RoboMarkets announce partnership br/br/ 23.09.2026 / 07:30 CET/CESTbr/ The issuer is solely responsible... Lire...
23/09/2026 07:30
EQS-News: Pyrum Innovations AG reports results for the first six months of 2026
html xmlns=http://www.w3.org/1999/xhtmlbody table border=trtd p EQSNews: Pyrum Innovations AG / Key words: Half Year Report br/ Pyrum Innovations AG reports results for the first six months of 2026 br/br/ 23.09.2026 / 07:30... Lire...
23/09/2026 07:30
ORPHAN SYNERGY EUROPE-PHARMA : OSE Immunotherapeutics Announces Presentation of Combi-TED Phase 2 Topline Results of Tedopi® in Non-Small Cell Lung Cancer at the ESMO 2026 Meeting
OSE Immunotherapeutics Announces Presentation of CombiTED Phase 2 Topline Results of Tedopi® in NonSmall Cell Lung Cancer at the ESMO 2026 Meeting Nantes, France, September 23, 2026 – 7:30am CET – OSE Immunotherapeutics SA ISIN: FR0012127173; Mnemo: OSE, a clinicalstage biotech company... Lire...
23/09/2026 07:30
SENSORION : Inside Information / News release on accounts, results
Press Release Sensorion Reports 2026 HalfYear Results, Provides Corporate Update and Announces Availability of HalfYear Report • Clinical Trial Applications CTAs for SENS601 GJB2GT, the Company’s lead gene therapy program for GJB2related hearing... Lire...
23/09/2026 07:30
Tocvan Ventures Corp. : Tocvan Expands El Mezquite; Drilling Returns 106.8 m of 0.5 g/t Au
pstrong id=datelineHERMOSILLO, MX / a href=https://www.accessnewswire.com/ACCESS Newswire/a / September 23, 2026 / /strongTocvan Ventures Corp. the "Company" or "Tocvan" CSE:TOCOTCQB:TCVNFWKN:TV3/A2PE64 is pleased to announce new drill results from the El Mezquite trend at its... Lire...
23/09/2026 07:00
Helvetia Holding AG : Helvetia Baloise successfully places a CHF 275 million subordinated bond
html xmlns=http://www.w3.org/1999/xhtmlbody table border= cellpadding= cellspacing=trtd p Helvetia Baloise Holding AG / Key words: Bond br/ Helvetia Baloise successfully places a CHF 275 million subordinated bond br/br/span23.09.2026 / 07:00... Lire...
23/09/2026 07:00
EQS-News: KWS closes a successful fiscal year 2024/2025 and lays the foundations for profitable growth
html xmlns=http://www.w3.org/1999/xhtmlbody table border=trtd p EQSNews: KWS SAAT SE & Co. KGaA / Key words: Annual Report br/ KWS closes a successful fiscal year 2024/2025 and lays the foundations for profitable growth br/br/ 23.09.2026 /... Lire...